HLA-DQ2 and HLA-DQ8: What Your Celiac Disease Genes Mean
8 min read · Last reviewed: August 2026 · Vytautas Jazbutis
On this page+
You Got HLA Results. Now What?
Maybe you saw HLA-DQ2 or HLA-DQ8 mentioned in a genetic test result. Maybe a doctor ordered it because of unexplained digestive symptoms, or you found it in a report from 23andMe or AncestryDNA raw data. Either way, you are looking at two of the most important genetic markers in celiac disease — and understanding what they mean can save you years of unnecessary dietary restriction or, conversely, prompt you to get the testing you actually need.
What Are HLA-DQ2 and HLA-DQ8?
HLA stands for Human Leukocyte Antigen. The HLA system is part of your immune system — it helps your body distinguish between its own cells and foreign invaders. HLA genes produce proteins that sit on the surface of your cells and present fragments of molecules (peptides) to T cells so your immune system can decide whether to react.
HLA-DQ2 and HLA-DQ8 are specific variants of the HLA-DQ gene. They produce proteins that are particularly good at binding to gluten peptides (specifically deamidated gliadin peptides) and presenting them to T cells. When this happens in the small intestine, it can trigger the autoimmune inflammatory response that defines celiac disease.
In simple terms: these gene variants create the immunological hardware that makes celiac disease possible. Without them, the autoimmune reaction to gluten essentially cannot occur.
The Greater Than 99% Rule
This is the single most important thing to understand about HLA-DQ2 and HLA-DQ8 testing:
Over 99% of people with confirmed celiac disease carry HLA-DQ2 or HLA-DQ8.
Virtually all confirmed celiac disease patients carry one or both of these markers. Rare case reports of celiac disease in HLA-DQ2/DQ8 negative individuals exist, but they are extraordinarily uncommon and often debated in the literature. This is why clinical HLA typing that finds neither marker is one of the most powerful rule-out tools in medicine — not for diagnosing celiac disease, but for ruling it out. If you have been wondering whether your symptoms could be celiac, and clinical typing is negative for both HLA-DQ2 and HLA-DQ8, you can move on with high confidence and investigate other causes.
This rule describes clinical HLA typing, ordered through a lab. As covered below, a consumer DNA result (like the tag SNPs read from 23andMe or AncestryDNA data) is a different, less reliable proxy for the same genes — a negative result there should not, by itself, be used to rule out celiac disease.
HLA-DQ2 vs. HLA-DQ8: What's the Difference?
Both variants can enable celiac disease, but they are not equally common among celiac patients:
- HLA-DQ2 (specifically the DQ2.5 haplotype) is present in approximately 90–95% of celiac disease patients. It is the primary genetic risk factor.
- HLA-DQ8 accounts for most of the remaining 5–10% of celiac patients who do not carry DQ2.
- Some individuals carry both HLA-DQ2 and HLA-DQ8, which is associated with a somewhat higher risk of developing celiac disease.
There is also a DQ2.2 haplotype that carries a lower but non-zero risk. Comprehensive testing considers DQ2.5, DQ2.2, and DQ8.
What If You Test Positive?
Here is where many people get confused: carrying HLA-DQ2 or HLA-DQ8 does not mean you have celiac disease.
Approximately 30–40% of the general population carries HLA-DQ2 or HLA-DQ8. Only about 1–3% of those carriers will ever develop celiac. These genes are necessary for celiac but not sufficient — other genetic factors, environmental triggers, and immune regulation all play a role.
If you test positive for HLA-DQ2 or HLA-DQ8 and have symptoms (chronic diarrhea, bloating, fatigue, iron deficiency, unexplained weight loss), the recommended next step is serological testing:
- tTG-IgA (tissue transglutaminase IgA) — the primary screening blood test for celiac disease
- Total serum IgA — to rule out IgA deficiency, which can cause false-negative tTG results
Important: You must be eating gluten regularly for serological testing to be accurate. If you have already gone gluten-free, the antibodies may not be detectable even if you have celiac disease. This is a common reason for inconclusive results.
Can 23andMe Test for HLA-DQ2 and HLA-DQ8?
Yes. 23andMe's genotyping array includes tag SNPs that can identify HLA-DQ2 and HLA-DQ8 haplotypes. These SNPs are in your raw data file, even though 23andMe does not display celiac genetics in its consumer reports.
DecodeMyBio's Celiac & Gluten Screening analyzes these tag SNPs from your 23andMe (or AncestryDNA) raw data and reports your HLA-DQ2/DQ8 status. Because it relies on tag SNPs rather than direct HLA typing, it is informative but not equivalent to a clinical HLA test — tag SNPs are less reliable outside people of European descent, and a negative result should not, by itself, be used to rule out celiac disease. See a sample celiac screening report.
For a detailed walkthrough of how this works: celiac genetic testing from 23andMe data.
What About Gluten Sensitivity?
Non-celiac gluten sensitivity (NCGS) is a different condition. People with NCGS experience symptoms when eating gluten but do not have the autoimmune intestinal damage that defines celiac disease. Crucially, NCGS has no known genetic marker. HLA-DQ2/DQ8 testing is specifically for celiac disease — it tells you nothing about gluten sensitivity.
If clinical HLA typing is negative for both HLA-DQ2 and HLA-DQ8, celiac is essentially ruled out. A negative consumer tag-SNP screening result (like the one described above) is reassuring but should not, by itself, be treated with the same certainty. Either way, you could still have NCGS, which is diagnosed clinically (by symptom response to gluten elimination and reintroduction) rather than genetically. For more: celiac vs. gluten sensitivity and should I go gluten-free?
When HLA Testing Is Most Useful
HLA-DQ2/DQ8 testing is particularly valuable in these scenarios:
- You have a first-degree relative with celiac. Risk is 5–15% in first-degree relatives. A negative HLA result can remove that uncertainty.
- You went gluten-free before getting tested. If antibody tests are now unreliable because you stopped eating gluten, HLA testing can still determine whether celiac was ever genetically possible.
- You have ambiguous or borderline antibody results. A negative HLA result tips the balance strongly against celiac.
- You simply want to know your risk. If you already have 23andMe or AncestryDNA data, checking your HLA status with Decode is free to start and takes minutes.
Check your HLA-DQ2/DQ8 status from your existing DNA data. Decode celiac & gluten screening is free to start and works with 23andMe or AncestryDNA raw data. Upload your data →
References
- Rubio-Tapia A, et al. American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. Am J Gastroenterol. 2023;118(1):59-76. PMID: 36602836.
- Husby S, et al. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr. 2020;70(1):141-156. PMID: 31568151.
- Lindfors K, et al. Coeliac disease. Nat Rev Dis Primers. 2019;5(1):3. PMID: 30631077.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Celiac Disease Tests — HLA-DQ2.5/DQ8 genetic testing.
- Monsuur AJ, et al. Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS One. 2008;3(5):e2270. PMID: 18509540.
- Catassi C, et al. Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders. Nutrients. 2013;5(10):3839-3853. PMID: 24077239.
- Baaqeel RH, et al. TagSNP approach for HLA risk allele genotyping of Saudi celiac disease patients: effectiveness and pitfalls. Biosci Rep. 2021;41(6):BSR20210509. PMID: 34042155.
- 23andMe for Healthcare Professionals. New 23andMe Report on Celiac Disease.
DecodeMyBio provides informational pharmacogenomic and genomic insights only. This is not medical or nutritional advice. Always consult your healthcare provider before making medication or supplement changes.
How this content is created and kept current: Methodology · Editorial policy · Limitations